High prevalence of emphysema and its association with BMI: A study of smokers with normal spirometry

Scandinavian Journal of Primary Health Care

Volumn 26, Issue 4, 2008, Pages 241-247

  Stratelis, Georgios ^a,b,d   Fransson, Sven Göran ^b   Schmekel, Birgitta ^b   Jakobsson, Per ^b   Mölstad, Sigvard ^b,c  

^a Primary Care Centre Vårdcentralen Brinken   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c Unit of Research   (Sweden)

^d NONE   (Sweden)

Author keywords

Body mass index; Computed tomography; Family practice; Pulmonary emphysema; Smoking; Spirometry

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANAMNESIS; ARTICLE; BODY MASS; CLINICAL EXAMINATION; DENSITOMETRY; EMPHYSEMA; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; GENERAL PRACTICE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG EMPHYSEMA; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PARASEPTAL EMPHYSEMA; PREVALENCE; SEPTUM PELLUCIDUM; SMOKING; SPIROMETRY;

BODY MASS INDEX; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY EMPHYSEMA; QUESTIONNAIRES; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; SMOKING; SPIROMETRY; SWEDEN; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 57049129922     PISSN: 02813432     EISSN: 15027724     Source Type: Journal    
DOI: 10.1080/02813430802452732     Document Type: Article

References (32)

1. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): A consensus statement of the European Respiratory Society (ERS). Eur Respir J 1995;8:1398-420.
2. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Cri Care Med 2001;163:1256-76.
3. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV 1. The Lung Health Study. JAMA 1994;272:1497-505.
4. US Department of Health and Human Services. The health benefits of smoking cessation: A report of the Surgeon General, 1990. DHHS Publication No (CDC) 90-8416. Rockville, MD: Public Health Service, Centers for Disease Control, Office on Smoking and Health; 1990.
5. Stratelis G, Jakobsson P, Mölstad S, Zetterstrom O. Early detection of COPD in primary care: Screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract 2004;54:201-6.
6. Kanner RE. Preclinical COPD: Description, recognition, and therapy. In: Cherniack, editor. Chronic obstructive pulmonary disease. Philadelphia: WB Saunders; 1991. p. 420-5.
7. Ekberg-Jansson A, Andersson B, Bake B, et al. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med 2001;95:363-73.
8. Remy-Jardin M, Remy J, Boulenguez C, Sobaszek A, Edme JL, Furon D. Morphologic effects of cigarette smoking on airways and pulmonary parenchyma in healthy adult volunteers: CT evaluation and correlation with pulmonary function tests. Radiology 1993;186:107-15.
9. Klein JS, Gamsu G, Webb WR, Golden JA, Muller NL. High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity. Radiology 1992;182:817-21.
10. Tylen U, Boijsen M, Ekberg-Jansson A, Bake B, Lofdahl CG. Emphysematous lesions and lung function in healthy smokers 60 years of age. Respir Med 2000;94:38-43.
11. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1994;7:1197-8.
12. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-81.
13. Park KJ, Bergin CJ, Clausen JL. Quantitation of emphysema with three-dimensional CT densitometry: Comparison with two-dimensional analysis, visual emphysema scores, and pulmonary function test results. Radiology 1999;211:541-7.
14. Vehmas T, Kivisaari L, Huuskonen MS, Jaakkola MS. Effects of tobacco smoking on findings in chest computed tomography among asbestos-exposed workers. Eur Respir J 2003;21:866-71.
15. Vikgren J, Boijsen M, Andelid K, et al. High-resolution computed tomography in healthy smokers and never-smokers: A 6-year follow-up study of men born in 1933. Acta Radiol 2004;45:44-52.
16. Stern EJ, Frank MS. CT of the lung in patients with pulmonary emphysema: Diagnosis, quantification, and correlation with pathologic and physiologic findings. AJR 1994;162:791-8.
17. Sahto K, Kobayashi T, Misao T, Hitani Y, Yamamoto Y, Nishiyama Y, Ohkawa M. CT assessment of subtypes of pulmonary emphysema in smokers. Chest 2001;120:725-9.
18. Geijer RM, Sachs AP, Verheij TJ, Lammers JW, Salomé PL, Hoes AW. Are patient characteristics helpful in recognizing mild COPD (GOLD I) in daily practice? Scand J Prim Health Care 2006;24:237-42.
19. Medbo A, Melbye H. What role may symptoms play in the diagnosis of airflow limitation? A study in an elderly population. Scand J Prim Health Care 2008;26:92-8.
20. Clark KD, Wardrobe-Wong N, Elliott JJ, Gill PT, Tait NP, Snashall PD. Patterns of lung disease in a "normal" smoking population: Are emphysema and airflow obstruction found together? Chest 2001;120:743-7.
21. Miniati M, Filippi E, Falaschi F, et al. Radiologic evaluation of emphysema in patients with chronic obstructive pulmonary disease: Chest radiography versus high resolution computed tomography. Am J Respir Crit Care Med 1995;151:1359-67.
22. Gurney JW, Jones KK, Robbins RA, et al. Regional distribution of emphysema: Correlation of high-resolution CT with pulmonary function tests in unselected smokers. Radiology 1992;183:457-63.
23. Vikgren J, Friman O, Borga M, Boijsen M, Gustavsson S, Ekberg-Jansson A, et al. Detection of mild emphysema by computed tomography density measurements. Acta Radiol 2005;46:237-45.
24. Gosker HR, Wouters EFM, Van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in COPD and chronic heart failure: Underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000;71:1033-47.
25. American Thoracic Society and European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1-40.
26. Goldstein SA, Thomashow BM, Kvetan V, Askanazi J, Kinney JM, Elwyn DH. Nitrogen and energy relationships in malnourished patients with emphysema. Am Rev Respir Dis 1988;138:636-44.
27. Donahoe M, Rogers RM, Wilson DO, Pennock BE. Oxygen consumption of the respiratory muscles in normal and malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989;140:385-91.
28. Bernard S, Leblanc P, Whittom F, et al. Peripheral muscle weakness in patient with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:629-34.
29. Debigare R, Cote CH, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease: Clinical relevance and mechanisms. Am J Respir Crit Care Med 2001;164:1712-7.
30. Vernooy JH, Kucukaycan M, Jacobs JA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: Soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002;166:1218-24.
31. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest 2002;121:127-30.
32. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003;21:347-60.